The effect of soy milk on levothyroxine absorptio
- Conditions
- levothyroxine absortptionlevothyroxine absorptionsoy milk
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
1. Healthy volunteers
2. Aged 18-45 years
3. Written informed consent by volunteer
1. Adults with recent acute illness, cardiovascular disease/abnormal electrocardiogram, renal insufficiency (serum creatinine >1.5 mg/dL), abnormal liver function (AST and/or ALT > 3 times of upper normal limit)
2. Use of certain medications that interfere with levothyroxine absorption such as iron, calcium, proton pump inhibitor, sucralfate, aluminium hydroxide, cholestyramine; affect with levothyroxine metabolism such as phenytoin, carbamazepine, phenobarbital, rifampicin, tyrosine kinase inhibitor
3. Use of certain medications that alter thyroid hormone levels such as amiodaraone, lithium, interfereon-alpha, alemtuzumab, glucocorticoid, somatostatin
4. Use of certain medications that affect with thyroxine-binding globulin such as estrogen, raloxifene, tamoxifen, mitotane, fluorouracil, methadone, heroin, androgen, nicotinic acid
5. Adults who had intestinal absorption problem or history of gastric/intestinal surgery
6. Adults with allergy to soy and/or levothyroxine
7. Pregnant women/lactating women
8. Adults who has abnormal TSH concentrations
9. Denied to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evothyroxine absorption test October 2019-September 2020 Area under the curve (AUC) of serum total T4 concentration
- Secondary Outcome Measures
Name Time Method analgesic usage until patient get operative fixation morphine dose requirement,complication until patient get operative fixation observe ex pressure sore peroneal nerve palsy